The latest report by IMARC Group, titled “Anti-Rheumatics Market Report by Type (Prescription-based Drugs, Over-the-Counter Drugs), Drug Class (Disease Modifying Anti-Rheumatics Drugs (DMARD's), Nonsteroidal Anti-Inflammatory Drugs (NSAID's), Corticosteroids, Uric Acid Drugs, and Others), Route of Drug Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce), and Region 2024-2032“, The global anti-rheumatics market size reached US$ 64.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 80.4 Billion by 2032, exhibiting a growth rate (CAGR) of 2.4% during 2024-2032.
Autoimmune and inflammatory rheumatic disorders impact the joints, tendons, ligaments, bones, and muscles, resulting in symptoms such as joint pain, stiffness, tenderness, and swelling, as well as systemic effects like weight loss, fever, fatigue, and weakness. Treatment generally involves a variety of medications, including disease-modifying anti-rheumatic drugs (DMARDs), non-steroidal anti-inflammatory drugs (NSAIDs), and medications to manage uric acid levels. The primary objectives of these treatments are to prevent joint damage, reduce inflammation, and slow the advancement of the disease.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/anti-rheumatics-market/requestsample
Anti-Rheumatics Market Trends and Drivers:
The global market is currently witnessing favorable growth, primarily attributed to the increasing aging demographic and the rising incidence of rheumatoid arthritis. Detrimental dietary habits, lack of physical activity, and the consequent rise in obesity are exacerbating the symptoms associated with rheumatoid arthritis. Additionally, the growing number of diabetes cases among the population is further fueling market expansion. There is a notable rise in awareness regarding various treatment options for anti-rheumatics, which is significantly contributing to market growth. Moreover, the market is being bolstered by increased investments in research and development (RD) initiatives aimed at the introduction of new therapies and efforts to lower medication costs. Other contributing factors include rising disposable incomes, enhanced affordability of rheumatoid arthritis treatments, and the widespread accessibility of both prescription and over-the-counter medications, all of which are positively impacting the market.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- Prescription-based Drugs
- Over-the-Counter Drugs
Breakup by Drug Class:
- Disease Modifying Anti-Rheumatics Drugs (DMARD's)
- Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
- Corticosteroids
- Uric Acid Drugs
- Others
Breakup by Route of Drug Administration:
- Oral
- Parenteral
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca plc
- Biogen Inc.
- Bristol-Myers Squibb Company
- Celltrion Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Johnson Johnsons
- Pfizer Inc.
- Sanofi SA
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
